medigraphic.com
ISSN 0016-3813 (Print)

2011, Number 3

<< Back Next >>

Gac Med Mex 2011; 147 (3)

Pre-hospital treatment of ophidian accidents: review, update, and current problems

Gil-Alarcón G, Sánchez-Villegas MC, Reynoso VH

Language: Spanish
References: 93
Page: 195-208
PDF size: 136.26 Kb.


ABSTRACT

Mythic, out-dated, ambiguous and sometimes iatrogenic procedures, still remain in pre-hospital and hospital ophidian accident treatment. Errors, omissions and ignorance make ophidian accidents appear more dangerous than they truly are, resulting in a general public contempt toward snakes. Here we present an updated review of current knowledge on pre-hospital and hospital treatment of ophidian bite incidents, including indications, recommendations and logic errors. We describe an appropriate treatment for native Mexican poisonous snakebites using fabotherapics, based on our experience. Adequate initial pre-hospital and hospital management is crucial for a successful outcome of this medical emergency. We describe the state of the art in snake bite research discussing those procedures where research is needed to implement them either by the patient, first responders, paramedics and doctors. We suggest proposals to achieve even more efficient management of fabotherapics based on support networks. Finally, we emphasize prevention as the main subject of venom bite treatment, as it is always more adequate and economic to invest in prevention than to spend on mitigation during emergency and recovery.


REFERENCES

  1. Frayre-Torres M, Sevilla-Godinez J, Orozco-Valerio E, Armas J, Celis A. Mortalidad por contacto traumático con serpiente y lagarto venenosos. Gac Med Mex. 2006;142:209-13.

  2. Fry GB, Winkel KD, Wickramaratna JC, Hodgson WC, Wüster W. Effectiveness of snake antivenom: Species and regional venom variation and its clinical impact. J Toxicol. 2003;22:23-34.

  3. Simpson ID, Norris RL. Snake antivenom product guidelines in India: “The devil is in the details”. Wilderness Environ Med. 2007;18:163-8.

  4. Boyd JJ, Agazzi G, Svajda D, Morgan AJ, Ferrandis S, Norris RL. Venomous snakebite in mountainous terrain: prevention and management. J Environ Med. 2007;18:190-202.

  5. Stewart ME, Greenland S, Hoffman JR. First-aid treatment for poisonous snakebite: Are currently recommended procedures justified?. Ann Emerg Med. 1981;10:331-5.

  6. Blackman RL, Dillon S. Venomous snakebite: Past, present, and future treatment options. J Am Board Fam Pract. 1992;5:339-405.

  7. Kricher JC. A neotropical companion: An introduction to the animals, plants and ecosystems of the new world tropics. Nueva Jersey: Princeton University Press; 1997.

  8. Forgey WW. Wilderness Medical Society. Practice Guidelines for Wilderness Emergency Care. Old Saybrook: Globe Pequot Press; 2000.

  9. Warrell DA. Features and treatment of snake bites in Belize. California: Natural World, Academic Press; 2000.

  10. Sotelo Cruz N. Envenenamiento por mordedura de serpiente de cascabel daños a la salud y su tratamiento en edad pediátrica. Gac Med Mex. 2003;139:317-24.

  11. Luna-Bauza ME. Mordedura por nauyaca Bothrops asper en niños. Boletín Médico del Hospital Infantil de México. 2004;61:102-5.

  12. García-De-Castro S, Vela-Fernández X. El manejo de las mordeduras de serpiente en Sudamérica. Emergencias. 2005;17:267-73.

  13. Ertem K, Esenkaya I, Kaygusuz MA, Turan C. Our clinical experience in the treatment of snakebites. Acta Orthop Traumatol Turc. 2005; 39:54-8.

  14. Chauhan S, Faruqui S, Bhalla A, Sharman N, Varma S, Bali J. Pre-hospital treatment of snake envenomation in patients presented at a tertiary care hospital in northwestern India. J Venom Anim Toxins incl Trop Dis. 2005;11:275-82.

  15. Pereda Cardoso C, Peña Atrio G, Ayala Chinea A. Mordeduras de serpientes. Rev Cubana Ortop Traumatol. 2007;21:1.

  16. Charry-Restrepo H. Manual básico para el tratamiento del accidente ofídico. Bogotá: Coodesca; 2007.

  17. Gold BS, Barish RA. Venomous snakebites current concepts in diagnosis, treatment and management. Emerg Med Clin North Am. 1992;9:833-42.

  18. Chippaux JP, Goyffon M. Venoms, antivenoms and immunotherapy. Toxicon. 1998;36:823-46.

  19. Rodríguez S, Negrin A, Burger M. Efecto adverso por suero antibothrópico. Rev Med Uruguay. 2004;20:228-32.

  20. López M. Serpiente y arácnidos venenosos daños, síntomas, métodos preventivos y tratamiento. México, D.F.: Trillas; 2007.

  21. Otero R. Seroterapia antivenenosa. Ventajas del uso de antivenenos del tipo IgG, F(ab’)2 o Fab en picaduras de escorpiones y mordeduras de serpientes. Pediatría. 2002;37:8-16.

  22. Otero R, Nuñez V, Barona J, Díaz A, Saldarriaga M. Características bioquímicas y capacidad neutralizante de cuatro antivenenos polivalentes frente a los efectos farmacológicos y enzimáticos de Bothrops asper y Porthidium nasutum de Antiquia y Chocó. IATREIA. 2002;15:5-15.

  23. Vega Franco L. Faboterapia ¿Será esta el fin de la seroterapia?. Medigraphic. 2007;74:59-60.

  24. Otero R. Epidemiological, clinical and therapeutic asper of Bothrops. Toxicon. 2009;54:998-1011.

  25. Hardy DL. Bothrops asper (viperidae) snakebite and field researchers in Middle America. Biotropica. 1994;26:198-207.

  26. Jasper EH, Miller M, Kennet J, Winder CP, Snyder JW, López BL. Venomous snakebites in an urban area: what are the possibilities? Wilderness Environ Med. 2000;11:168-71.

  27. Young BA, Zahn K. Venom flow in rattlesnakes: mechanics and metering. J Exp Biol. 2001;204:4345-51.

  28. Alvarado-Díaz J, Sauzo-Ortuño I. Reptiles venenosos de Michoacán. Morelia: Universidad Michoacana de San Nicolás de Hidalgo; 2006.

  29. Linner FA. A checklist of the amphibians and reptiles of México. Occasional papers of the Museum of Natural Science. 2007;80:1-59.

  30. Roodt R, Estévez–Ramírez AJ, Paniagua-Solis JF, et al. Toxicidad de venenos de serpientes de importancia médica en México. Gac Med Mex. 2004;141:13-21.

  31. Julia-Zertuche J. Reptiles mexicanos de importancia para la salud pública y su distribución geográfica. Sal Pub Mex. 1981;23:329-43.

  32. Tay ZJ, Díaz JG, Sánchez JT, Ruiz D, Castillo L. Serpientes y reptiles de importancia médica en México. Revista de la Facultad de Medicina UNAM. 2002;45:212-9.

  33. Pizon AF. Prehospital assessment and treatment of envenomations. JEMS. 2007;32:76-88.

  34. Gutiérrez J. Comprendiendo los venenos de serpientes: 50 años de investigación en América Latina. Rev Biol Trop. 2002;50:337-94.

  35. Castrillón-Estrada DF, Acosta-Vélez J, Hernández-Ruiz E, Alonso Palacio L. Envenenamiento ofídico. Salud Uninorte. 2007;23:96-111.

  36. Blaylock R. Antibacterial properties of South African snake venoms. Toxicon. 1999;37:1336.

  37. White J. Bites and stings from venomous animals: A global overview. Ther Drug Monit. 2000;22:65-8.

  38. Gold BS, Dart RC, Barish RA. Bites of venomous snakes. N Engl J Med. 2002;347:347-56.

  39. Cuesta J, Zuluaga A, Peña L. ¿Es necesaria la profilaxis antibiótica en ofidiotoxicosis? Infect. 2008;12:280-9.

  40. Rajendra W, Armugam A, Jeyaseelan K. Toxins in anti-nociception and anti-inflamation. Toxicon. 2004;44:1-17.

  41. Lewis RJ, García ML. Therapeutic potential of venom peptides. Nat Rev Drug Discov. 2003;2:790-802.

  42. Klauber LM. Rattlesnake, their habits, life histories and influence o mankind. California: University of California Press; 1997.

  43. Mackessy SP. Venom ontogeny in the Pacific rattlesnakes Crotalus viridis helleri and C.v. oreganus. Copeia. 1998;1:92-101.

  44. Vázquez AH, Chávez-Haro A, García-Ubbelohde W, et al. Farmacocinética de un antídoto antialacránico F(ab’)2 en voluntarios humanos sanos. Toxicon. 2005;46:797-805.

  45. Theakston RD, Warrel DA, Griffiths E. Report of a WHO workshop on the standardization and control of antivenoms. Toxicon. 2003;41:541-57.

  46. Schöni R. The use of snake venom-derived compounds for new functional diagnostic test kits in the field of haemostasis. Pathophysiol Haemost Thromb. 2005;34:234-40.

  47. Ellenhorn MJ, Barcelloux DG. Medical Toxicology: Diagnosis and treatment of human poisoning. NY: Elsevier; 1988.

  48. Nishioka SA, Silveira PVP, Baulo FA. Bite marks are useful for the differential diagnosis of snakebites in Brazil. Wilderness Environ Med. 1995;6:184-90.

  49. Luna-Bauza ME. Bases para el tratamiento por intoxicación por veneno de serpiente. Revista de la Facultad de Medicina UNAM. 2007; 50:198-203.

  50. León G, Mongue M, Rojas E, Lomonte B, Gutiérrez JM. IgG and F(ab’)2 polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions. Toxicon. 2001;39:793-801.

  51. Sicherer SH, Simons FER. Quandaries in prescribing an emergency action plan and self-injectable epinephrine for first-aid management of anaphylaxis in the community. J Allergy Clin Immunol. 2005; 115:575-83.

  52. Soae J. Emergency treatment of anaphylactic reactions-guidelines for health care providers. Resuscitation. 2008;77:157-69.

  53. Markenson D, Ferguson JD, Chameides L, et al. Part 17: First Aid: 2010 American Heart Association and American Red Cross Guidelines for First Aid. Circulation. 2010;122:S934-46.

  54. Sánchez Villegas MCS. Mordeduras y picaduras. En: Temas selectos de urgencias. Magallón-Mariné J, González-García N (Eds.). México, D.F.: Editorial Prado; 2010.

  55. Tay ZJ, Castillo A, Romero R. Tratamiento de las mordeduras por serpientes ponzoñosas. Sal Pub Mex. 1981;23:457-72.

  56. Campbell JA, Lamar WW. The venomous reptiles of the western hemisphere. NY: Cornell University Press; 2004.

  57. Christopher DG, Rodning CB. Crotalidae envenomation. South Medical Journal. 1986;79:159-62.

  58. Morejón García M, Salup Diaz R. Ofidismo. Studio de 30 casos en Brasil. Rev Cubana Med Gen Integr. 2006;22:1-5.

  59. Wingert WA, Chan L. Rattlesnake bites in southern California and rationale for recommended treatment. West J Med. 1988;148:37-44.

  60. Ralidis PM. Medical treatment of reptile envenomation: A review of the current literature. Top Emerg Med. 2000;22:16-36.

  61. Diario Oficial de la Federación Norma Oficial Mexicana NOM-036-SSA2-2002 Prevención y control de enfermedades. Aplicación de vacunas, toxoides, sueros, antitoxinas e inmunoglobulinas en el humano. Diario Oficial de la Federación. 2003;598:51-77.

  62. Auerbach PS, Donner HJ, Weiss EA. Field guide to wilderness medicine. Missouri: Mosby Inc.; 1999.

  63. Shulov A, Ben-Shaul R, Nitzan R. The efficacy of suction as method of treatment in snake venom poisoning. Toxicon. 1969;7:15-8.

  64. Bush SP, Hegewald KG, Green SM, Cardwell MD, Hayes WK. Effects of a negative pressure venom extraction device (Extractor) on local tissue injury after artificial rattlesnake envenomation in porcine model. Wilderness Environ Med. 2000;11:180-8.

  65. Bush S. Snakebite suction devices don’t remove venom: they just suck. Ann Emerg Med. 2004;43:187-8.

  66. Alberts M, Shalit M, LoGalbo F. Suction for venomous snakebite: a study of “Mock Venom” extraction in human model. Ann Emerg Med. 2004;43:81-186.

  67. McKinney PE. Out-of-hospital and interhospital management of crotaline snakebite. Ann Emerg Med. 2001;38:607-8.

  68. Curtis H, Barnes NS. Biología. Buenos Aires: Médica Panamericana; 2001.

  69. Gellert A. More on snake-venom and insect-venom extractors. N Engl J Med. 1993;328:516-7.

  70. Ertem K. Venomous snake bite in turkey first aid and treatment. Eur J Gen Pract. 2004;1:1-6.

  71. Breiner MJ. Surgical treatment of envenomation injuries. Top Emerg Med. 2000;22:74-6.

  72. Dart RC, Gustafson RA. Failure of electric shock treatment for rattlesnake envenomation. Ann Emerg Med. 1991;20:659-61.

  73. Davis D, Branch K, Egen NB, Russell FE, Gerrish K, Auerbach PS. The effect of an electrical current on snake venom toxicity. Wilderness Environ Med. 1992;3:48-53.

  74. Patiño BS. Serpientes venenosas. Boletín GEAS. Colombia. 2002;3:37-42.

  75. Kerriagan R, Mertz B, Nelson J, Dye J. Antibiotic prophylaxis for pit envenomation: Prospective, controlled trial. World J Surg. 1997;21:369-73.

  76. Clark RF, Seldens BS, Furbee B. The incidence of wound infection following crotalid envenomation. Journal Emerg Med. 1993;11:583-6.

  77. Tagwireyi DD, Ball DE, Nhachi CFB. Routine prophylactic antibiotic use in the management of snakebite. BMC Clin Pharmacol. 2001;1:4.

  78. LoVecchio F, Klemens J, Welch S, Rodríguez R. Antibiotics after rattlesnake envenomation. J Emerg Med. 2002;23:327-8.

  79. Terry P, Mackway-Jones K. The use of antibiotics in venomous snake bite. Emerg Med J. 2002;19:48-9.

  80. Bustillo S, Leiva LC, Merino L, Acosta O, Bal de Kier Joffé E, Gorodner JO. Antimicrobial activity of Bothrops alternatus venom from the Northeast of Argentine. Revista Latinoamericana de Microbiología. 2008;50:79-82.

  81. Paul V, Pratibha S, Prahlad K, Earali J, Francis S, Lewis F. High-dose anti-snake venom versus low-dose anti-snake venom in treatment of poisonous snake bites- a critical study. J Assoc Physicians India. 2004;52:13-7.

  82. Habib AG. Tetanus complicating snakebite in Northern Nigeria: clinical presentation and public health implications. Acta Trop. 2003;85:87-91.

  83. Presutti RJ. Early treatment and prophylaxis against infectious complications. Postgrad Med. 1997;4:875-8.

  84. Fleisher GR. The management of bite wounds. N Engl J Med. 1999;340:138-40.

  85. Cottral GE. Microbiología veterinaria. México D.F.: La Prensa Médica Mexicana; 1986.

  86. Wen Fan H, Marcopito LF, Cardoso JLC, et al. Sequential randomized and double blind trial of promethazine prophylaxis against early anaphylactic reactions to antivenom for Bothrops snake bites. BMJ. 1999; 318:1451-2.

  87. Gaudio F, Lemery J, Johnson D. Recommendations on the use of epinephrine in outdoor education and wilderness settings. Wilderness Environ Med. 2010;21:185-7.

  88. Dassanayake AS, Karunanayake P, Kasturiratne KTAA, et al. Safety of subcutaneous adrenaline as prophylaxis against acute adverse reactions to anti-venom serum in snakebite. Ceylon Med J. 2002;47:48-9.

  89. Young-Siang S, Rutherford G. Evidence behind the WHO guidelines: Hospital care for children: Should s/c adrenaline, hydrocortisone or antihistamines be used as premedication for snake antivenom? J Trop Pediatr. 2006;52:155-77.

  90. Simpson ID, Norris RL. The global snakebite crisis-A public health issue misunderstood, not neglected. Wilderness Environ Med. 2009;20:43-56.

  91. Miami-Dade Fire Rescue Venom Response Program. Disponible en: http://www.miamidade.gov/mdfr/emergency_special_venom.asp. Revisado el 18 de febrero de 2011.

  92. Gil G, Zaldivar C. Ofidiotoxicosis, tratamiento prehospitalario y propuesta de manejo de un botiquín de emergencia especializado (BAO). Hidalgo: Universidad Autónoma del Estado de Hidalgo; 2008.

  93. Red Internacional de Centros de Referencia para el Control y Tratamiento de las Intoxicaciones por Animales Ponzoñosos. Disponible en: http://www.redtox.org/rt3/. Revisado el 18 de febrero de 2010.




2020     |     www.medigraphic.com